Saba Capital Management L.P. Raises Stock Position in Abrdn Life Sciences Investors (NYSE:HQL)

Saba Capital Management L.P. grew its stake in shares of Abrdn Life Sciences Investors (NYSE:HQL – Free Report) by 98.3% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 271,607 shares of the company’s stock after acquiring an additional 134,644 shares during the period. Saba Capital Management […]

Related Keywords

,Cornerstone Advisors ,Abrdn Life Sciences Investors Stock Performance ,Thomasj Herzfeld Advisors Inc ,Abrdn Life Sciences Investors Profile ,Quantedge Capital Pte Ltd ,Abrdn Life Sciences Investors ,Abrdn Life Sciences Investors Increases Dividend ,Quarter For Abrdn Life Sciences Investors ,Wolverine Asset Management ,Free Report ,Capital Pte Ltd ,Asset Management ,Life Sciences Investors ,Inc The ,Visit Holdingschannel ,Abrdn Life Sciences Investors Daily ,Nyse Hql ,Whql ,Finance ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,